Global Pet Dewormers Market By Pet (Dogs, Horses, Cats, Other), By Route of Administration (Oral, Injectable, Topical), By Dosage Form (Liquids, Tablets), By Type (Prescription, OTC), By Distribution Channel (Veterinary Hospitals/Clinics, Retail/Pet Stores, E-commerce), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview

The Global Pet Dewormers Market size is expected to be worth around USD 5.8 Billion by 2034, from USD 2.5 Billion in 2024, growing at a CAGR of 8.7% during the forecast period from 2025 to 2034.

Pet dewormers are products designed to eliminate parasitic worms in pets, primarily dogs and cats. These products play a crucial role in maintaining the health and well-being of pets by preventing infections caused by intestinal parasites such as roundworms, hookworms, and tapeworms. Dewormers are available in various forms, including tablets, chewables, topical treatments, and injectables.

The global demand for these products is growing, driven by an increasing awareness among pet owners regarding the importance of deworming for overall pet health. Additionally, rising pet ownership, especially in developed markets, has significantly expanded the dewormer market in recent years.

The pet dewormers market has experienced steady growth due to the increasing number of pet owners globally. In particular, countries with high pet ownership rates such as the UK and the US, where pet care is a priority, have witnessed a surge in demand for these products. For instance, according to Joiipetcare, around 34% of dogs in the UK have worms, highlighting the need for regular deworming treatments.

Additionally, a study from the National Center for Biotechnology Information (NCBI) revealed that the average deworming per year in the UK was 3.1 for both dogs and cats, which is below the minimum recommended by the European Scientific Counsel Companion Animal Parasites (ESCCAP). This indicates a significant opportunity for market growth as pet owners are encouraged to follow recommended deworming schedules.

There is a considerable opportunity in the pet dewormers market, particularly in emerging economies where pet ownership is increasing. As disposable incomes rise and pet care awareness grows in regions such as Asia-Pacific and Latin America, the demand for pet dewormers is expected to grow exponentially. Government investment in veterinary care and pet health is another key driver.

For instance, regulatory bodies such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) continue to regulate the approval and safety of deworming medications. The presence of these regulatory frameworks ensures that pet dewormers meet the required safety and efficacy standards, which builds consumer trust.

Follow-up deworming sessions, particularly in puppies and kittens, are critical for effective deworming treatment. According to PetCareRx, follow-up deworming sessions are recommended every 2 weeks until the dog is 8 weeks old. These guidelines further emphasize the importance of ensuring pets receive adequate treatment to prevent recurring infestations.

As more pet owners adhere to these practices, the market for pet dewormers will continue to expand, providing ample opportunities for both established brands and emerging players in the pet care space.

Key Takeaways

• The global Pet Dewormers Market is projected to reach USD 5.8 billion by 2034, growing at a CAGR of 8.7% from 2025 to 2034.
• Dogs held a dominant 37.6% share in the Pet Dewormers Market in 2024 due to high pet dog populations and increased deworming awareness.
• The Oral route of administration led the market in 2024, commanding 45.7% of the share, driven by convenience and ease of use.
• Liquid formulations were the preferred dosage form in 2024, holding a significant market share due to their ease of administration and palatability.
• Veterinary Hospitals/Clinics dominated the Pet Dewormers Market distribution channels in 2024, with a 40.08% share.
• North America held the largest market share in 2024 at 35.2%, valued at USD 0.8 billion, driven by growing pet ownership and spending on pet health.

Pet Analysis

Dogs lead Pet Dewormers Market with 37.6% share in 2024, driven by popularity and pet care awareness

In 2024, dogs held a dominant position in the By Pet Analysis segment of the Pet Dewormers Market, commanding a substantial 37.6% market share. This dominance is largely attributed to the high number of pet dogs globally and increasing awareness among pet owners about the importance of regular deworming.

As pet owners become more conscious of their dogs’ health, the demand for effective and safe deworming solutions has grown, particularly in regions with stringent pet care regulations.

Horses follow with a notable share in the market, driven by the rising need for deworming in the equine industry. Their specific deworming requirements, often linked to performance and overall health, have sparked increased sales of targeted deworming products for horses.

Cats, although a significant segment, occupy a smaller portion of the market compared to dogs, due to different health management practices and lower adoption rates in some regions. The Other category, which includes smaller pets like rabbits and guinea pigs, holds a minor yet steady share in the market, benefiting from niche deworming products tailored to their unique needs.

Overall, the Pet Dewormers Market remains highly influenced by the pet care trends surrounding dogs, with steady growth seen in other animal categories.

Route of Administration Analysis

Oral Route Dominates Pet Dewormers Market with 45.7% Share in 2024, Driven by Convenience and Efficacy

In 2024, the Oral route of administration emerged as the dominant segment in the Pet Dewormers market, accounting for an impressive 45.7% share. This dominance is largely driven by the growing preference for convenient, easy-to-administer treatments for pets.

Oral dewormers are widely favored due to their ease of consumption, typically in the form of tablets, chewables, or liquids, which reduces the stress and effort of both pet owners and veterinarians. Moreover, oral dewormers often offer broad-spectrum efficacy, making them a reliable choice for various parasitic infestations.

Following the oral route, the Injectable segment held a smaller share but is expected to show gradual growth as it is preferred for more severe infestations or in cases requiring immediate action. Injectable dewormers offer the benefit of long-lasting effects and precise dosing, but the need for veterinary intervention limits their widespread use.

The Topical segment, while beneficial for pets who may not tolerate oral medication, continues to occupy a modest share of the market. Topical dewormers are particularly favored for external parasites but face competition from oral treatments in internal deworming.

Overall, the oral route continues to lead, offering the best balance of convenience, effectiveness, and widespread adoption in the pet dewormers market.

Dosage Form Analysis

Liquids Lead Pet Dewormers Market in 2024, Capturing Significant Market Share

In 2024, liquids emerged as the dominant dosage form in the pet dewormers market, holding a notable market share. This preference for liquid formulations can be attributed to their ease of administration and high palatability, which makes them particularly appealing for pet owners of all types.

Liquids are often preferred for pets that are resistant to tablet ingestion, especially when it comes to cats and small dogs. The liquid form ensures accurate dosing and faster absorption, contributing to its widespread acceptance among both pet owners and veterinarians.

The convenience of liquid pet dewormers, paired with the ability to mix the solution with food or administer it directly, also supports their growing market presence. Additionally, liquid formulations often contain a combination of active ingredients that are highly effective in treating a wide spectrum of parasites, further increasing their demand in the market.

Tablets, while still a significant segment, face limitations in terms of palatability and ease of administration, particularly for more finicky pets. As a result, liquids continue to dominate, capitalizing on these advantages and appealing to the evolving needs of pet owners seeking hassle-free deworming solutions for their animals.

Distribution Channel Analysis

Veterinary Hospitals/Clinics Lead the Pet Dewormers Market with 40.08% Share in 2024

In 2024, Veterinary Hospitals/Clinics maintained a dominant position in the By Distribution Channel Analysis segment of the Pet Dewormers Market, holding a substantial 40.08% market share.

This significant share can be attributed to the trust pet owners place in veterinary professionals for administering deworming treatments, ensuring accuracy and safety. With growing awareness about pet health, more pet owners are turning to veterinary clinics for specialized deworming services tailored to their pets’ specific needs.

Retail/Pet Stores followed closely behind as a key distribution channel, capturing a noteworthy portion of the market. These stores continue to be a popular choice for pet owners seeking over-the-counter dewormers, given their convenience and the growing pet care retail industry. Pet stores provide accessibility and immediate purchase options for consumers, particularly those seeking a quick solution for mild infestations.

Meanwhile, the E-commerce segment has experienced a rapid rise in recent years, as online shopping offers convenience and easy access to a wide variety of pet deworming products. With digital platforms facilitating better customer engagement, the e-commerce channel continues to expand, especially as more pet owners opt for home delivery and the convenience of purchasing products online.

Key Market Segments

By Pet

• Dogs
• Horses
• Cats
• Other

By Route of Administration

• Oral
• Injectable
• Topical

By Dosage Form

• Liquids
• Tablets

By Type

• Prescription
• OTC

By Distribution Channel

• Veterinary Hospitals/Clinics
• Retail/Pet Stores
• E-commerce

Drivers

Increased Pet Ownership Fuels Growing Demand for Pet Dewormers

The pet dewormers market is being driven by several key factors. Firstly, the rise in pet ownership, especially following the COVID-19 pandemic, has led to a surge in demand for products that support pet health, including dewormers. As more people adopt pets, the need for responsible pet care, including regular deworming, becomes increasingly important.

Alongside this, there is a growing awareness among pet owners about the role deworming plays in maintaining overall pet health, with many now recognizing it as essential to prevent health issues caused by parasitic infections. The prevalence of these infections is rising due to factors like poor hygiene, outdoor activities, and changing climates that contribute to increased exposure to parasites. This is driving pet owners to seek out reliable deworming solutions.

Additionally, advancements in technology have brought new, more effective deworming options to market, such as long-acting medications and formulations that are easier to administer, further encouraging adoption. Together, these factors are contributing to a strong growth trajectory for the pet dewormers market as pet owners prioritize the health and well-being of their animals.

Restraints

High Cost of Premium Pet Dewormers Limits Accessibility

The high cost of premium pet deworming products is a key restraint in the market. While these products often promise advanced formulas and better efficacy, their higher price tags make them less accessible to budget-conscious pet owners. This limits their adoption, especially among individuals with limited financial resources or those with multiple pets.

As a result, many pet owners opt for more affordable, but possibly less effective, alternatives. This price barrier is particularly evident in regions where disposable incomes are lower, and pets may not always be seen as a high-priority expense. In addition, the perceived value of these premium products may not be fully recognized, especially when some pet owners are unaware of the long-term health risks that can arise from inadequate deworming.

This reluctance to invest in pricier options hampers the overall market potential, especially in emerging markets where pet ownership is rising but economic constraints remain. In such markets, more education and awareness about the benefits of premium dewormers could help increase demand and shift consumer behavior over time.

Growth Factors

Expanding in Emerging Markets Fuels Pet Dewormer Growth

The pet dewormers market is set to experience significant growth, particularly in emerging regions like Asia-Pacific, Africa, and Latin America. In these areas, rising pet ownership, increased awareness about pet health, and improvements in healthcare infrastructure are driving demand for deworming products. As pet care becomes a growing priority, there is an opportunity to expand product availability and education to reach new consumers.

Additionally, product innovation plays a crucial role, with brands developing more convenient and appealing deworming options, such as chewable tablets, flavored treatments, and products that combine deworming with flea and tick prevention. These innovations cater to different consumer preferences and make deworming easier for pet owners.

Strategic partnerships with veterinary clinics can also help boost brand loyalty and increase the effectiveness of targeted deworming campaigns.

Lastly, as more pet owners seek natural and organic options for their pets, companies have the chance to diversify their product lines and tap into this growing demand for environmentally friendly and chemical-free solutions.

Overall, the combination of geographic expansion, innovation, veterinary collaboration, and sustainability is creating ample opportunities for growth in the pet dewormer market.

Emerging Trends

Personalized Pet Deworming Treatments Gaining Popularity

The pet dewormers market is seeing several key trends, driven by changing consumer preferences and evolving pet care needs. One major trend is the growing demand for personalized pet healthcare, where deworming treatments are customized based on a pet’s breed, age, or health condition.

This approach reflects a broader shift toward more tailored, effective care for pets. Alongside this, eco-conscious pet owners are pushing for sustainable, eco-friendly packaging for pet products, including dewormers. This demand for greener solutions aligns with the broader trend toward environmental responsibility.

Another key trend is the rise of subscription-based models for pet medications, offering convenience and ensuring that pet owners stay on top of their pets’ health needs with regular deliveries of dewormers.

Lastly, there is an increasing interest in holistic pet care, where deworming treatments are paired with other health products like nutrition supplements to provide a comprehensive approach to pet wellness. This shift highlights the growing focus on overall health rather than just treating individual issues, ensuring pets receive well-rounded care that supports their long-term well-being.

Regional Analysis

North America Leads Pet Dewormers Market with 35.2% Share at USD 0.8 Billion

North America is the dominant region in the global pet dewormers market, accounting for 35.2% of the market share, valued at USD 0.8 billion in 2024. The region’s growth is driven by increasing pet ownership, heightened awareness of pet health, and rising spending on pet care.

The U.S., in particular, represents the largest market due to its high pet population and the growing trend of premium pet products. Additionally, stringent regulations concerning pet health and a robust distribution network support the market expansion in this region.

Regional Mentions:

Europe holds a significant share of the market, with demand driven by rising awareness of zoonotic diseases, increasing adoption of pets, and government initiatives supporting pet health. The market benefits from a growing trend toward premium pet care products and an increasing preference for natural deworming solutions.

Asia Pacific is experiencing rapid growth, fueled by increasing pet ownership, urbanization, and rising disposable income in countries like China, India, and Japan. The shift towards premium pet products and heightened consumer awareness regarding pet health contribute significantly to this expansion.

Middle East & Africa and Latin America are smaller markets but are witnessing steady growth due to increased pet ownership, particularly in urban areas, and growing awareness of pet healthcare.

In conclusion, North America remains the dominant region in the global pet dewormers market, with significant contributions from Europe and Asia Pacific.

Key Regions and Countries

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

Key Players Analysis

In 2024, the global pet dewormers market remains highly competitive, with several key players positioning themselves as industry leaders through strategic investments, innovations, and geographic expansions.

Zoetis, a dominant force in animal health, continues to leverage its broad portfolio of parasiticide products, further strengthening its market presence. The company’s focus on research and development has resulted in the introduction of novel deworming treatments, enhancing its competitive advantage.

Virbac and Vetoquinol, both of which maintain a strong presence in the veterinary pharmaceutical sector, have adopted aggressive market expansion strategies, especially in emerging markets. Their focus on improving pet health through affordable, effective solutions ensures they meet growing demand, particularly in the Asia-Pacific region.

Boehringer Ingelheim’s robust product pipeline and acquisitions, such as its purchase of Merial, have fortified its position in the dewormer segment. The company’s commitment to innovation in parasiticide formulations, coupled with its extensive global distribution network, solidifies its leadership status.

Hester Biosciences Limited and Merck & Co., Inc. are increasingly recognized for their commitment to advanced pet healthcare solutions. Hester Biosciences has gained a reputation for cost-effective products catering to developing markets, while Merck’s established global brand drives trust in their high-quality deworming solutions.

Dechra Pharmaceuticals Plc. and Elanco Animal Health maintain a strong market foothold through strategic product differentiation, emphasizing the efficacy of their products. Ceva Santé Animale and Intas Pharmaceuticals Ltd. focus on increasing their market share through a combination of product innovation and expanding their veterinary service offerings.

Top Key Players in the Market

• Zoetis
• Virbac
• Vetoquinol
• Boehringer Ingelheim
• Hester Biosciences Limited
• Merck & Co. Inc.
• Dechra Pharmaceuticals Plc.
• Elanco Animal Health
• Ceva Sante Animale
• Intas Pharmaceuticals Ltd.

Recent Developments

• In Feb 2024, pet care startup Supertails raised $15 million in funding to fuel its expansion, with a particular focus on growing its private label business and diversifying product offerings for pets.
• In Feb 2024, pet care brand Papa Pawsome successfully secured $400,000 in a seed funding round, aiming to scale its operations and strengthen its position in the growing pet care market.
• In Jan 2025, Heads Up For Tails initiated fresh talks to raise $40 million from a combination of new and existing investors, capitalizing on the pet care sector’s rapid growth and consumer demand.

Report Scope